Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CGTL | Creative Global Technology | $2.30 | $1.14 | 98.28% | 412.1K | $35M | $0.41$7.24 |
| ACON | Aclarion | $8.89 | $3.14 | 54.65% | 41.7M | $3.9M | $4.32$1,241.88 |
| ELVN | Enliven Therapeutics | $23.50 | $8.03 | 51.91% | 8.2M | $918M | $13.30$25.59 |
| NEOG | Neogen | $9.78 | $2.40 | 32.45% | 17.9M | $1.6B | $3.87$12.98 |
| BEG | Themes ETF Trust - Leverage Shares 2x Long Be Daily ETF | $26.15 | $5.73 | 28.05% | 21.6K | - | $10.89$27.69 |
| ASPC | A Spac III Acquisition Corp. | $20.69 | $4.35 | 26.62% | 1.1M | $38M | $9.97$63.98 |
| MLTX | MoonLake Immunotherapeutics | $14.26 | $2.97 | 26.31% | 22.4M | $800M | $5.95$62.75 |
| NVVE | Nuvve | $4.34 | $0.83 | 23.65% | 28.3M | $4.7M | $1.98$200.80 |
| SATL | Satellogic | $2.96 | $0.56 | 23.13% | 14.2M | $325M | $1.26$5.12 |
| ZENA | ZenaTech | $4.12 | $0.77 | 22.84% | 2.2M | $110M | $1.82$7.11 |
Related Articles
Featured Article
2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street
Cory Renauer|Nov 20, 2022
Recent analyst upgrades suggest these stocks can triple your money or better.
Is It Too Late to Jump In on Zentalis?
James Halley|Jun 3, 2020
The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
David Haen|Apr 23, 2020
These companies just raised significant cash to advance promising drug pipelines.
Advertisement
3 Recession-Ready Stocks to Buy Right Now
Scott Levine|Feb 21, 2020
When looking to fortify your portfolio, it's best to keep things simple.
Double Your Money with This Biotech
David Haen|Jan 24, 2020
With its first FDA approval in hand, a second, more lucrative indication looms on the horizon.
5 Biggest New Drug Approvals Potentially on the Way in 2019
Keith Speights|Aug 19, 2019
FDA approvals for these drugs could translate to billions of dollars for a few companies.
Why CenturyLink, Jabil, and Neogen Slumped Today
Dan Caplinger|Sep 25, 2018
Find out how earnings news affected some of these companies.
3 Biotech Stocks That Soared This Week: Are They Buys?
Keith Speights|Oct 14, 2017
Good news from clinical studies and a scrapped acquisition help powered these biotech stocks to huge gains this week.
Why Spartan Motors, Ardelyx, and Glu Mobile Jumped Today
Dan Caplinger|Oct 12, 2017
Even as banks took the spotlight, these stocks gained ground. Find out why.
With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory?
David Liang|May 29, 2017
Shares of Synergy are down, but things are looking up for this GI gem
